ClinicalTrials.Veeva

Menu

A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)

Organon logo

Organon

Status and phase

Completed
Phase 4

Conditions

Asthma

Treatments

Drug: Comparator: placebo
Drug: MK0476; montelukast sodium

Study type

Interventional

Funder types

Industry

Identifiers

NCT00140881
0476-165
2005_055

Details and patient eligibility

About

A 53-week study to determine the effect of montelukast sodium when given to children (with infrequent episodic asthma) at the earliest symptoms of an acute episode of asthma.

Enrollment

220 patients

Sex

All

Ages

2 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Males or females between the ages of 2 and 14 who have infrequent episodic asthma.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems